CTRI/2024/05/067300
Not yet recruiting
Phase 4
Effectiveness of injection hyperbaric ropivacaine(0.75%) with injection hyperbaric bupivacaine(0.5%) in lower segment cessarian section under spinal anesthesia; randomized double blind controlled trial - nil
Keerthana0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: 4- Measurement and Monitoring
- Sponsor
- Keerthana
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing cesarean section and with ASA Grade I/II/III
Exclusion Criteria
- •History of allergy to local anaesthetic to study drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A comparison of spinal bupivacaine and ropivacaine heavy in pregnant patients undergoing caesarian surgery .Health Condition 1: O269- Pregnancy related conditions, unspecifiedCTRI/2023/04/051367MGM Medical College and Hospital Aurangabad
Not yet recruiting
Not Applicable
Comparison between hyperbaric Ropivacaine and hyperbaric Bupivacaine in patients undergoing inguinal and perineal surgeries under spinal anaesthesia.Health Condition 1: O- Medical and SurgicalCTRI/2023/02/050035Dr D Y Patil Medical college Hospital and Research Centre Pune
Not yet recruiting
Not Applicable
Effectiveness of injection hyperbaric bupivacaine(0.5%) and injection hyperbaric levobupivacaine(0.5%) in caserean section under spinal anaesthesiaHealth Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2023/04/051935Govt medical College and sir t hospital Bhavnagar
Not yet recruiting
Phase 4
Comparision of Hyperbaric Ropivacaine Alone or with Fentanyl in Spinal Anaesthesia for Abdominal HysterectomyCTRI/2024/05/067077I
Not yet recruiting
Phase 4
A comparative study between ropivacaine versus levobupivacaine for spinal anaesthesiaHealth Condition 1: O- Medical and SurgicalCTRI/2024/05/067639Dr Sunil chiruvella